Clinical Trial Update: Interest of Placental Alpha-microglobulin-1 Detection Test to Assess Risk of Premature Delivery in Reunion Island [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating the placental alpha-microglobulin-1 (PAMG-1) detection test to assess the risk of preterm delivery in Reunion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Snippet

Sponsor: Centre Hospitalier Universitaire de la Réunion | Conditions: Premature Delivery | Phase 4 | Status: UNKNOWN